Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20201201003
TCTR20201201003
Recruiting
Phase 3

The efficacy of topical recombinant human epidermal growth factor gel in combination with fractional radiofrequency microneedle in the treatment of mild to moderate atrophic acne scar, A randomized split-face clinical study

none0 sites20 target enrollmentDecember 1, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsmild to moderate rolling and shallow boxcar acne scars

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
mild to moderate rolling and shallow boxcar acne scars
Sponsor
none
Enrollment
20
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2020
End Date
December 7, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • •1\.mild to moderate rolling and shallow boxcar acne scars more than 6 months

Exclusion Criteria

  • •1\.Use isotretanoin or Vitamin A derivative drugs within 6 months
  • •2\.Have a laser treatment for acne scars within 6 months
  • •3\.History of topical anesthesia allergy
  • •4\.Patient using cardiac pacemaker or defibrillator
  • •5\.Patient that skin prone to keloid easily

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
Healing of mouth soft tissues using topically applied gel.
CTRI/2023/01/049177OFFICE OF DGDS
Completed
Not Applicable
The clinical benefit of topical moisturizers in xerosis patientDiseases of the skin and subcutaneous tissue
KCT0001508Samsung Medical Center80
Not yet recruiting
Phase 4
To compare the clinical outcome of topical recombinant human epidermal growth factor and conventional saline dressing in management of diabetic foot ulcers - a randomised controlled trial
CTRI/2024/06/068922Aarupadai veedu medical College and hospital
Not yet recruiting
Phase 3
Effect of topical recombinant human epidermal growth factor on chronic diabetic ulcer compared with conventional saline dressing
CTRI/2024/05/067239Dr A Sneha Daffodil
Completed
Not Applicable
Comparison of topical recombinant human epidermal growth factor versus aloe vera gel in combination with ablative 10,600-nm carbon dioxide fractional laser for the treatment of striae alba: A randomized, double-blind trialStriae albastriae alba&#44recombinant&#45human epidermal growth factor&#44fractional carbon dioxide laser
TCTR20180610001Thammasat University24